- Home
- BCLI vs CREG Comparison
BCLI vs CREG Comparison
Compare BCLI & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- CREG
- Stock Information
- Founded
- BCLI 2000
- CREG 1980
- Country
- BCLI United States
- CREG China
- Employees
- BCLI N/A
- CREG N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- CREG Power Generation
- Sector
- BCLI Health Care
- CREG Utilities
- Exchange
- BCLI Nasdaq
- CREG Nasdaq
- Market Cap
- BCLI 6.4M
- CREG 6.7M
- IPO Year
- BCLI N/A
- CREG N/A
- Fundamental
- Price
- BCLI $1.21
- CREG $0.68
- Analyst Decision
- BCLI Strong Buy
- CREG
- Analyst Count
- BCLI 1
- CREG 0
- Target Price
- BCLI $30.00
- CREG N/A
- AVG Volume (30 Days)
- BCLI 118.2K
- CREG 166.9K
- Earning Date
- BCLI 11-14-2024
- CREG 11-08-2024
- Dividend Yield
- BCLI N/A
- CREG N/A
- EPS Growth
- BCLI N/A
- CREG N/A
- EPS
- BCLI N/A
- CREG N/A
- Revenue
- BCLI N/A
- CREG N/A
- Revenue This Year
- BCLI N/A
- CREG N/A
- Revenue Next Year
- BCLI N/A
- CREG N/A
- P/E Ratio
- BCLI N/A
- CREG N/A
- Revenue Growth
- BCLI N/A
- CREG N/A
- 52 Week Low
- BCLI $1.05
- CREG $0.63
- 52 Week High
- BCLI $11.85
- CREG $2.00
- Technical
- Relative Strength Index (RSI)
- BCLI 23.69
- CREG 38.02
- Support Level
- BCLI $1.05
- CREG $0.68
- Resistance Level
- BCLI $1.95
- CREG $0.71
- Average True Range (ATR)
- BCLI 0.20
- CREG 0.04
- MACD
- BCLI -0.00
- CREG -0.00
- Stochastic Oscillator
- BCLI 15.84
- CREG 4.62
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.